Burke William Patrick - Sep 1, 2021 Form 3 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Human Resources Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for William Patrick Burke
Stock symbol
NVCR
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
3
Date filed
9/3/2021, 04:34 PM
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVCR Ordinary Shares 10.3K Sep 1, 2021 Direct
holding NVCR Restricted Share Units 2.66K Sep 1, 2021 Direct F1
holding NVCR Restricted Share Units 4.8K Sep 1, 2021 Direct F2
holding NVCR Restricted Share Units 1.57K Sep 1, 2021 Direct F3
holding NVCR Restricted Share Units 3.27K Sep 1, 2021 Direct F4
holding NVCR Restricted Share Units 3.63K Sep 1, 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 17.5K $11.46 Direct F6
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 9.75K $7.15 Direct F6
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 7.5K $21.60 Direct F7
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 32.1K $21.15 Direct F8
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 10.9K $47.04 Direct F9
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 13.9K $69.37 Direct F10
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 4.54K $84.68 Direct F11
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 6K $153.09 Direct F12
holding NVCR Options to Buy Ordinary Shares Sep 1, 2021 Ordinary Shares 6.53K $137.58 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units that are scheduled to vest on March 22, 2022, subject to the reporting person's continued employment through such date.
F2 Represents restricted share units that are scheduled to vest on March 3, 2022 and 2023, subject to the reporting person's continued employment through such dates.
F3 Represents restricted share units that are scheduled to vest on September 1, 2022 and 2023, subject to the reporting person's continued employment through such dates.
F4 Represents restricted share units that are scheduled to vest on March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
F5 Represents restricted share units that are scheduled to vest on September 1, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
F6 Fully vested as of the date hereof.
F7 These options vest on October 31, 2021, subject to the reporting person's continued employment through such date.
F8 Options to buy 32,103 ordinary shares, 24,078 shares of which are currently exercisable and the remaining 8,025 vest and become exercisable on February 27, 2022, subject to the reporting person's continued employment through such date.
F9 Options to buy 10,946 ordinary shares, 3,649 shares of which are currently exercisable and the remaining 7,297 shares of which will vest and become exercisable in equal installments on each of March 22, 2022 March 22, 2023, subject to the reporting person's continued employment through such dates.
F10 Options to buy 13,896 ordinary shares, 3,474 shares of which are currently exercisable and the remaining 10,422 shares will vest and become exercisable in equal installments on each of March 3, 2022, March 3, 2023 and March 3, 2024, subject to the reporting person's continued employment through such dates.
F11 Options to buy 4,535 ordinary shares, 1,134 shares of which are currently exercisable and the remaining 3,401 shares will vest and become exercisable in equal installments on each of September 1, 2022, September 1, 2023 and September 1, 2024, subject to the reporting person's continued employment through such dates.
F12 One-quarter of these options is scheduled to vest on each of March 2, 2022, March 2, 2023, March 2, 2024 and March 2, 2025, subject to the reporting person's continued employment through such dates.
F13 One-quarter of these options is scheduled to vest on each of September 1, 2022, September 1, 2023, September 1, 2024 and September 1, 2025, subject to the reporting person's continued employment through such dates.